Treatment of adenocarcinoma with combinations of cyclopjosphamide (NSC-26271), vincristine (NSC-67574), and 5-fluorouracil (NSC-19893).

MLA

Tucker, W. G., et al. “Treatment of Adenocarcinoma with Combinations of Cyclopjosphamide (NSC-26271), Vincristine (NSC-67574), and 5-Fluorouracil (NSC-19893).” Cancer Chemotherapy Reports, vol. 59, no. 2 Pt 1, Mar. 1975, pp. 425–27. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=1097101&authtype=sso&custid=ns315887.

APA

Tucker, W. G., Talley, R. W., Lane, M., & Bonnet, J. D. (1975). Treatment of adenocarcinoma with combinations of cyclopjosphamide (NSC-26271), vincristine (NSC-67574), and 5-fluorouracil (NSC-19893). Cancer Chemotherapy Reports, 59(2 Pt 1), 425–427.

Chicago

Tucker, W G, R W Talley, M Lane, and J D Bonnet. 1975. “Treatment of Adenocarcinoma with Combinations of Cyclopjosphamide (NSC-26271), Vincristine (NSC-67574), and 5-Fluorouracil (NSC-19893).” Cancer Chemotherapy Reports 59 (2 Pt 1): 425–27. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=1097101&authtype=sso&custid=ns315887.